ATE131873T1 - Cytokine - Google Patents
CytokineInfo
- Publication number
- ATE131873T1 ATE131873T1 AT90810481T AT90810481T ATE131873T1 AT E131873 T1 ATE131873 T1 AT E131873T1 AT 90810481 T AT90810481 T AT 90810481T AT 90810481 T AT90810481 T AT 90810481T AT E131873 T1 ATE131873 T1 AT E131873T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- polypeptides
- mediators
- hybrid vectors
- dnas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Control Of Transmission Device (AREA)
- Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
- Radar Systems Or Details Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898915414A GB8915414D0 (en) | 1989-07-05 | 1989-07-05 | Novel cytokines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE131873T1 true ATE131873T1 (de) | 1996-01-15 |
Family
ID=10659582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90810481T ATE131873T1 (de) | 1989-07-05 | 1990-06-26 | Cytokine |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5411882A (de) |
| EP (1) | EP0412050B1 (de) |
| JP (1) | JPH0356499A (de) |
| AT (1) | ATE131873T1 (de) |
| AU (1) | AU649226B2 (de) |
| CA (1) | CA2020303A1 (de) |
| DD (1) | DD298948A5 (de) |
| DE (1) | DE69024279T2 (de) |
| DK (1) | DK0412050T3 (de) |
| ES (1) | ES2081960T3 (de) |
| GB (1) | GB8915414D0 (de) |
| GR (1) | GR3018521T3 (de) |
| IE (1) | IE70519B1 (de) |
| PT (1) | PT94575B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2052602T3 (es) * | 1986-10-03 | 1994-07-16 | Ciba Geigy Ag | Nuevos peptidos afines a las linfocinas. |
| ATE311895T1 (de) | 1992-05-26 | 2005-12-15 | Immunex Corp | Neue zytokine die cd30 binden |
| US6645493B1 (en) * | 1993-05-17 | 2003-11-11 | The Picower Institute For Medical Research | Composition containing anti-MIF antibody |
| US6774227B1 (en) * | 1993-05-17 | 2004-08-10 | Cytokine Pharmasciences, Inc. | Therapeutic uses of factors which inhibit or neutralize MIF activity |
| UY27304A1 (es) | 2001-05-24 | 2002-12-31 | Avanir Pharmaceuticals | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación |
| TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| CN1839133A (zh) * | 2003-08-22 | 2006-09-27 | 阿文尼尔药品公司 | 作为巨噬细胞移动抑制因子的抑制剂的取代的二氮杂萘衍生物及其在治疗人类疾病中的应用 |
| WO2006068398A1 (en) | 2004-12-20 | 2006-06-29 | Isu Abxis Co., Ltd. | Molecules inhibition intercellular adhesion |
| US7740856B2 (en) * | 2005-12-20 | 2010-06-22 | Isu Abxis Co., Ltd. | Effect of BST2 on inflammation |
| US8329186B2 (en) * | 2004-12-20 | 2012-12-11 | Isu Abxis Co., Ltd | Treatment of inflammation using BST2 inhibitor |
| US20080299128A1 (en) * | 2006-06-20 | 2008-12-04 | Myung Kim | Effect of Bst2 on inflammation |
| WO2006102191A1 (en) * | 2005-03-24 | 2006-09-28 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| MXPA05011139A (es) * | 2005-10-17 | 2007-04-17 | Concretos Translucidos S De R | Formulacion para obtener una mezcla de concreto conductivo. |
| GB0605689D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
| US9249217B2 (en) * | 2010-12-03 | 2016-02-02 | Secretary, DHHS | Bispecific EGFRvIII x CD3 antibody engaging molecules |
| US9958456B2 (en) | 2011-10-07 | 2018-05-01 | Baxalta Incorporated | OxMIF as a diagnostic marker |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0672158B2 (ja) * | 1984-05-24 | 1994-09-14 | チバ−ガイギ− アクチエンゲゼルシヤフト | 精製されたヒトマクロファージ遊走阻止因子 |
| US5008374A (en) * | 1986-03-14 | 1991-04-16 | Otsuka Pharmaceutical Co., Ltd. | IL-1α derivatives and drugs |
| ES2052602T3 (es) * | 1986-10-03 | 1994-07-16 | Ciba Geigy Ag | Nuevos peptidos afines a las linfocinas. |
| ATE149176T1 (de) * | 1987-10-02 | 1997-03-15 | Univ Rockefeller | Von makrophagen abstammender entzündungsvermittler(mip-1-alpha et mip-1-beta) |
-
1989
- 1989-07-05 GB GB898915414A patent/GB8915414D0/en active Pending
-
1990
- 1990-06-26 DK DK90810481.3T patent/DK0412050T3/da active
- 1990-06-26 AT AT90810481T patent/ATE131873T1/de not_active IP Right Cessation
- 1990-06-26 ES ES90810481T patent/ES2081960T3/es not_active Expired - Lifetime
- 1990-06-26 EP EP90810481A patent/EP0412050B1/de not_active Expired - Lifetime
- 1990-06-26 DE DE69024279T patent/DE69024279T2/de not_active Expired - Fee Related
- 1990-07-02 AU AU58095/90A patent/AU649226B2/en not_active Ceased
- 1990-07-03 PT PT94575A patent/PT94575B/pt not_active IP Right Cessation
- 1990-07-03 DD DD90342467A patent/DD298948A5/de not_active IP Right Cessation
- 1990-07-03 CA CA002020303A patent/CA2020303A1/en not_active Abandoned
- 1990-07-04 IE IE242690A patent/IE70519B1/en not_active IP Right Cessation
- 1990-07-05 JP JP2176488A patent/JPH0356499A/ja active Pending
-
1991
- 1991-12-20 US US07/811,893 patent/US5411882A/en not_active Expired - Fee Related
-
1995
- 1995-12-21 GR GR950403656T patent/GR3018521T3/el unknown
-
1996
- 1996-09-27 US US08/714,927 patent/US5821336A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0356499A (ja) | 1991-03-12 |
| AU5809590A (en) | 1991-01-10 |
| PT94575B (pt) | 1997-02-28 |
| EP0412050A1 (de) | 1991-02-06 |
| IE70519B1 (en) | 1996-12-11 |
| IE902426A1 (en) | 1991-06-19 |
| ES2081960T3 (es) | 1996-03-16 |
| DE69024279T2 (de) | 1996-10-17 |
| DD298948A5 (de) | 1992-03-19 |
| AU649226B2 (en) | 1994-05-19 |
| GB8915414D0 (en) | 1989-08-23 |
| GR3018521T3 (en) | 1996-03-31 |
| DE69024279D1 (de) | 1996-02-01 |
| PT94575A (pt) | 1991-03-20 |
| EP0412050B1 (de) | 1995-12-20 |
| US5411882A (en) | 1995-05-02 |
| US5821336A (en) | 1998-10-13 |
| DK0412050T3 (da) | 1996-01-29 |
| CA2020303A1 (en) | 1991-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE131873T1 (de) | Cytokine | |
| WO1990010709A3 (en) | Monoclonal antibodies for metallic cations on small molecules | |
| DE69630710D1 (de) | Humaner tumornekrosefaktor delta und epsilon | |
| ATE131872T1 (de) | Latenz assoziierte peptide und deren verwendung | |
| DE69721548D1 (de) | HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN | |
| CY1109093T1 (el) | Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι | |
| ATE183241T1 (de) | Impstoff gegen streptococcus suis-infektion | |
| FI873410A0 (fi) | Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita | |
| KR900701318A (ko) | 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체 | |
| DE69504959D1 (de) | Humanisierte monoklonale antikörper gegen humanes interleukin - 4 | |
| DK592086A (da) | Humant conglutinin | |
| ES8800052A1 (es) | Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale | |
| DE3570677D1 (en) | Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation | |
| DE3579808D1 (de) | Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung. | |
| WO2000017363A3 (en) | Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses | |
| WO1999019480A3 (en) | Human receptor proteins; related reagents and methods | |
| ITTO911003A0 (it) | Metodo rapido per l'identificazione dello s.aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi. | |
| DK182188A (da) | Humant tumorassocieret antigen | |
| GR890100333A (en) | Antihuman antigen antibodies | |
| BG48881A1 (en) | Hybridomic cell line mus musculus h 5/9, secretizing monoclonal antibodies against rickettsia conorii | |
| ATE124722T1 (de) | Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung. | |
| WO2001046419A3 (en) | Mammalian prion proteins; related reagents and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |